Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:RE:100$ stock price

[MrMugsy]

crow27 wrote: Lets think about this again.   Dec 18/20 NR, they are working on combining AH with ATE.
This is what I am thinking but I could be wrong so correct me if I am.

The holding company (AH) is worth something (it has a dollar value) and it is a totally separate company from ATE. The holding company has shares and no one seems to know exactly how many but lets say it's 15 million shares. The holding company shares are NOT the same value as ATE shares because they are 2 different companies.
I say this because if Dan and management feel the holding company is worth (this is a total guess) lets say 50 million dollars that would mean that each share in AH is worth (50 million dollars divided by 15 million shares = $3.33) Remember AH is a separate company.
Now if they want to combiine the 2 companies then ATE would have to issue ATE shares to the owners of AH. As mentioned above if Dan feels that AH is worth 50 million then we would take 50 million dollars and divide it by $5.88 which is the price of an ATE share Therfore we would have to issue roughly 8.5 million shares of ATE to Dan and the gang, the owners of AH.
Now that would be dilution but you just bought something worth 50 million dollars so in fact the share price of ATE would not go down. We would then now have aprox 47.5 million shares in the combined company which is ATE.
How many shares of ATE we issue to the AH owners is dependent on how much they say the company is worth not how many shares AH has. It's the dollar value of AH that counts.
I think this is why this is not that simple, what is the true fair market value of AH?
If AH is worth 100 million then we have to issue 17 million shares of ATE.100 mill divided by $5.88
If the market feels that the value of AH is fair to ATE shareholders when this takes place then the SP of ATE should not decline. If it is unfair then it goes down and if it is more than fair we go up.

Dan and the gang are going to make the money big time no matter how this goes down.
Remember that this AH company is worth something otherwise ATE would not be basically buying it.
Correct me if I'm out to lunch

You are right Crow.

For us to cointinue and develop the first three drugs, there is no additional value to 2030/32.

The additional value comes here ...
There is additional value if we can get new IP for additional years of protection.
There is additional value if they can create new IP for new drugs.

They are working hard "right now" to find carriers and to increase AH's value.
If we combine, then we translate all of that to ATE's value to partners or an acquirer.

In my opinion.